全文获取类型
收费全文 | 825篇 |
免费 | 78篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 66篇 |
妇产科学 | 107篇 |
基础医学 | 64篇 |
口腔科学 | 13篇 |
临床医学 | 48篇 |
内科学 | 135篇 |
皮肤病学 | 5篇 |
神经病学 | 36篇 |
特种医学 | 64篇 |
外科学 | 98篇 |
综合类 | 10篇 |
预防医学 | 52篇 |
眼科学 | 66篇 |
药学 | 58篇 |
肿瘤学 | 85篇 |
出版年
2021年 | 13篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 17篇 |
2017年 | 18篇 |
2016年 | 13篇 |
2015年 | 25篇 |
2014年 | 36篇 |
2013年 | 26篇 |
2012年 | 19篇 |
2011年 | 41篇 |
2010年 | 25篇 |
2009年 | 32篇 |
2008年 | 26篇 |
2007年 | 36篇 |
2006年 | 41篇 |
2005年 | 32篇 |
2004年 | 25篇 |
2003年 | 18篇 |
2002年 | 30篇 |
2001年 | 32篇 |
2000年 | 13篇 |
1999年 | 17篇 |
1998年 | 24篇 |
1997年 | 34篇 |
1996年 | 34篇 |
1995年 | 21篇 |
1994年 | 29篇 |
1993年 | 17篇 |
1992年 | 18篇 |
1991年 | 17篇 |
1990年 | 15篇 |
1989年 | 22篇 |
1988年 | 12篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1985年 | 14篇 |
1984年 | 4篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1944年 | 2篇 |
1939年 | 5篇 |
1937年 | 1篇 |
1912年 | 1篇 |
1911年 | 1篇 |
排序方式: 共有907条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
5.
6.
7.
8.
9.
Using a newly devised 50-channel photometer which records the opacity of growing bacterial cultures, it was shown that the time taken by cultures diluted 1/1000 in fresh broth to reach 50% of the opacity of a fully grown culture was inversely related to the concentration of organisms in the original culture. This relation was used to determine the numbers of survivors after exposure to benzylpenicillin and gentamicin alone and in combination. The procedure is commended as a labour-saving and potentially rapid method of obtaining comprehensive information on the bactericidal action and interaction of antibiotics. 相似文献
10.
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer 总被引:55,自引:0,他引:55
Morris M Eifel PJ Lu J Grigsby PW Levenback C Stevens RE Rotman M Gershenson DM Mutch DG 《The New England journal of medicine》1999,340(15):1137-1143
BACKGROUND AND METHODS: We compared the effect of radiotherapy to a pelvic and para-aortic field with that of pelvic radiation and concurrent chemotherapy with fluorouracil and cisplatin in women with advanced cervical cancer. Between 1990 and 1997, 403 women with advanced cervical cancer confined to the pelvis (stages IIB through IVA or stage IB or IIa with a tumor diameter of at least 5 cm or involvement of pelvic lymph nodes) were randomly assigned to receive either 45 Gy of radiation to the pelvis and para-aortic lymph nodes or 45 Gy of radiation to the pelvis alone plus two cycles of fluorouracil and cisplatin (days 1 through 5 and days 22 through 26 of radiation). Patients were then to receive one or two applications of low-dose-rate intracavitary radiation, with a third cycle of chemotherapy planned for the second intracavitary procedure in the combined-therapy group. RESULTS: Of the 403 eligible patients, 193 in each group could be evaluated. The median duration of follow-up was 43 months. Estimated cumulative rates of survival at five years were 73 percent among patients treated with radiotherapy and chemotherapy and 58 percent among patients treated with radiotherapy alone (P=0.004). Cumulative rates of disease-free survival at five years were 67 percent among patients in the combined-therapy group and 40 percent among patients in the radiotherapy group (P<0.001). The rates of both distant metastases (P<0.001) and locoregional recurrences (P<0.001) were significantly higher among patients treated with radiotherapy alone. The seriousness of side effects was similar in the two groups, with a higher rate of reversible hematologic effects in the combined-therapy group. CONCLUSIONS: The addition of chemotherapy with fluorouracil and cisplatin to treatment with external-beam and intracavitary radiation significantly improved survival among women with locally advanced cervical cancer. 相似文献